According to Gram Research analysis of 340 ICU patients, low vitamin C at hospital admission is strongly linked to severe body-wide inflammation. A specific inflammation score (SIRS) predicted vitamin C deficiency with 67.4% accuracy, and combining it with another severity score improved accuracy to 71.1%. About 59% of ICU patients studied had some degree of vitamin C shortage.
A Gram Research analysis of 340 critically ill patients found that those with low vitamin C levels at hospital admission showed stronger signs of severe inflammation. Researchers discovered that a specific inflammation score (SIRS) was better at predicting vitamin C deficiency than other common illness severity measures. When doctors combined two scoring systems, they could even more accurately identify which patients had dangerously low vitamin C. This matters because vitamin C helps fight inflammation and supports immune function, so understanding this connection could help doctors better care for their sickest patients.
Key Statistics
A 2026 observational study of 340 ICU patients found that the SIRS inflammation score predicted vitamin C deficiency with 67.4% accuracy, outperforming three other commonly used illness severity measures.
Among 340 critically ill patients admitted to the ICU, 59% had insufficient or deficient vitamin C levels, with 25.9% classified as insufficient and 33.3% as severely deficient.
Combining SIRS and APACHE II scores improved the predictive accuracy for vitamin C deficiency to 71.1% in a 2026 study of 340 ICU patients, compared to 67.4% for SIRS score alone.
A 2026 research analysis of 340 ICU admissions showed that inflammation markers (SIRS score) were better predictors of vitamin C deficiency than nutritional risk screening or organ failure assessment scores.
The Quick Take
- What they studied: Whether patients admitted to intensive care units with low vitamin C levels also showed signs of severe body-wide inflammation
- Who participated: 340 adults admitted to ICU between January 2021 and January 2022. About 41% had normal vitamin C, 26% had low levels, and 33% had severe deficiency
- Key finding: A specific inflammation measurement (SIRS score) was better at predicting vitamin C deficiency than other illness severity scores, with 67.4% accuracy. Combining two scoring systems improved accuracy to 71.1%
- What it means for you: For critically ill patients, checking vitamin C levels and inflammation markers together may help doctors identify who needs vitamin C support. However, this is observational research—it shows a connection but doesn’t prove vitamin C treatment will help
The Research Details
Researchers looked back at medical records from 340 patients who were admitted to intensive care units over one year. When each patient arrived at the ICU, doctors measured their vitamin C levels in the blood. The team then compared these vitamin C levels to several different scoring systems doctors use to measure how sick patients are. These scoring systems measure things like body temperature, heart rate, breathing rate, and blood cell counts—all signs of severe inflammation. The researchers wanted to see which scoring system was best at predicting who had low vitamin C.
This type of study is called observational because researchers watched what happened naturally rather than giving some patients vitamin C and others a placebo. They collected information that was already being measured as part of normal medical care. This approach is useful for finding connections between things, but it can’t prove that one thing causes another.
Understanding which patients are most likely to have vitamin C deficiency could help doctors decide who needs vitamin C supplementation in the ICU. Since vitamin C is important for immune function and fighting inflammation, identifying deficiency early might improve outcomes. The study shows that inflammation measurements might be a practical way to spot vitamin C problems without always needing blood tests.
This study included a reasonable number of patients (340) and measured vitamin C at a consistent time point (admission). However, it’s observational, meaning it can show connections but not prove cause-and-effect. The study was conducted at a single time point, so researchers couldn’t track whether vitamin C levels changed or how patients recovered. The research was published in a peer-reviewed medical journal, which means other experts reviewed it before publication. The accuracy of the best-performing scoring system (71.1%) is moderate—good enough to be useful but not perfect for predicting vitamin C deficiency.
What the Results Show
Among the 340 ICU patients studied, the SIRS score (which measures signs of body-wide inflammation) was the single best predictor of vitamin C deficiency, correctly identifying deficiency 67.4% of the time. This was better than three other commonly used illness severity scores: APACHE II, NRS, and SOFA. When researchers combined the SIRS score with the APACHE II score (which measures organ function and age), the accuracy improved to 71.1%—meaning this combination was better at spotting patients with low vitamin C.
The patients were divided into three groups based on vitamin C levels: 126 patients (40.8%) had sufficient vitamin C, 80 patients (25.9%) had insufficient levels, and 103 patients (33.3%) had severe deficiency. This means about 59% of ICU patients in this study had some degree of vitamin C shortage. The researchers found measurable differences in blood chemistry and vital signs between these groups, suggesting that vitamin C deficiency is connected to how severely ill these patients are.
The study showed that different illness severity scores performed differently at predicting vitamin C deficiency. APACHE II alone had lower predictive accuracy than SIRS, and NRS and SOFA scores were also less effective. This suggests that inflammation markers (measured by SIRS) are more closely connected to vitamin C status than other measures of illness severity. The fact that combining two scores improved accuracy suggests that vitamin C deficiency involves multiple aspects of critical illness, not just inflammation alone.
Previous research has shown that vitamin C is important in critical illness, but studies specifically looking at baseline vitamin C levels when patients arrive at the ICU have been limited. This study fills that gap by examining a large group of ICU patients at admission. The finding that inflammation scores predict vitamin C deficiency aligns with what scientists know about vitamin C’s role in controlling inflammation and supporting immune function. However, this is one of the first studies to specifically test which illness severity scores best predict vitamin C deficiency.
This study only measured vitamin C once—when patients arrived at the ICU. It didn’t track whether vitamin C levels changed during hospitalization or how patients recovered, so we can’t know if low vitamin C actually caused worse outcomes. The study was observational, meaning it shows connections but can’t prove that vitamin C deficiency causes inflammation or that treating it would help. The accuracy of even the best-performing score combination (71.1%) means it misses about 29% of patients with vitamin C deficiency. The study was conducted at a single hospital or healthcare system, so results might differ in other settings. The study doesn’t tell us whether giving vitamin C supplements to deficient patients would improve their condition.
The Bottom Line
For ICU doctors: Consider checking vitamin C levels in critically ill patients, especially those with high inflammation scores. The combination of SIRS and APACHE II scores may help identify who needs vitamin C assessment. For patients and families: This research suggests vitamin C status matters in critical illness, but it doesn’t yet prove that supplements will help. Any vitamin C supplementation should be decided by the ICU medical team based on individual patient needs. Confidence level: Moderate—this shows a real connection but more research is needed to determine if treatment helps.
ICU doctors and nutritionists should pay attention to this research when caring for critically ill patients. Patients with severe infections, sepsis, or multiple organ problems may be at higher risk for vitamin C deficiency. People planning to study critical care nutrition should consider this work. However, this research doesn’t directly apply to healthy people or those with mild illness—it’s specifically about the sickest hospitalized patients.
This research doesn’t address how quickly vitamin C deficiency develops or how fast it can be corrected. In the ICU setting, vitamin C status can change rapidly, so doctors would need to monitor levels regularly rather than relying on a single measurement.
Frequently Asked Questions
What is the connection between vitamin C levels and how sick ICU patients are?
Low vitamin C at ICU admission is linked to higher inflammation markers. A 2026 study of 340 patients found that inflammation scores predicted vitamin C deficiency 67.4% of the time, suggesting vitamin C and inflammation are connected in critical illness.
How common is vitamin C deficiency in people admitted to intensive care?
According to a 2026 study of 340 ICU patients, about 59% had some vitamin C shortage—26% had insufficient levels and 33% had severe deficiency. Only 41% had adequate vitamin C when admitted.
Can doctors use inflammation scores to predict which ICU patients need vitamin C?
Partially. A 2026 study found that combining inflammation scores (SIRS) with organ function scores (APACHE II) predicted vitamin C deficiency 71.1% of the time—useful but not perfect for identifying all deficient patients.
Does this research prove that vitamin C supplements help critically ill patients?
No. This study shows vitamin C deficiency is connected to severe illness and inflammation, but it doesn’t prove that supplements improve outcomes. More research testing actual vitamin C treatment is needed.
Should healthy people worry about vitamin C deficiency based on this study?
This research applies only to critically ill ICU patients, not healthy people. The study doesn’t address vitamin C needs in normal health or mild illness. Healthy people typically get enough vitamin C from diet.
Want to Apply This Research?
- For ICU care teams using nutrition tracking apps: Log SIRS scores, APACHE II scores, and vitamin C levels at admission and regularly during stay. Track the combination score (SIRS + APACHE II) to identify high-risk patients for vitamin C deficiency
- Implement a protocol where ICU patients with SIRS scores above a certain threshold automatically get vitamin C level screening at admission. Use app alerts to flag patients with combined high SIRS and APACHE II scores for nutritional assessment
- Create a dashboard showing the percentage of ICU admissions with vitamin C deficiency and how well the combined SIRS/APACHE II score predicts it. Track whether early identification of vitamin C deficiency leads to earlier supplementation and monitor patient outcomes over time
This research describes an association between vitamin C levels and inflammation in critically ill patients but does not prove that vitamin C deficiency causes severe illness or that supplements will improve outcomes. This study is observational and cannot establish cause-and-effect relationships. Vitamin C supplementation in ICU patients should only be considered under medical supervision and as part of a comprehensive treatment plan. This information is for educational purposes and should not replace professional medical advice. Anyone with questions about vitamin C status or supplementation in critical illness should consult with their healthcare team.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.